Hunter Holmes McGuire VA Medical Center
Hunter Holmes McGuire VA Medical Center
Richmond, Virginia, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-10-02 | NCT02768363 | |
| Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-10-02 | NCT01436968 | |
| Cryotherapy for Locally Advanced Esophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Phase 1 | 2026-09-18 | NCT04248582 | |
| Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-25 | NCT06052176 | |
| Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease | Alcohol Use Disorder, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-related disorders, cirrhosis of liver, liver disorder, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-24 | NCT05548452 | |
| A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, metabolic dysfunction-associated steatohepatitis | Active, not recruiting | Phase 3 | 2026-07-08 | NCT05500222 | |
| Microbiome Modulation With Prebiotics in PTSD and Cirrhosis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stress Disorders, Traumatic, acute stress disorder, cirrhosis of liver, liver disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Not applicable | 2026-04-09 | NCT06464952 | |
| Oral Health In Cirrhosis of the Liver (ORACLE) | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, cirrhosis of liver, mouth disorder, periodontal disorder | Active, not recruiting | Not stated | 2026-04-03 | NCT06052150 | |
| Epidural Stimulation and Resistance Training After SCI | central nervous system disorder, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury | Recruiting | Phase 2 / Phase 3 | 2026-01-02 | NCT04782947 | |
| CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2025-08-22 | NCT04495153 |